Actionable Patient Safety Solutions (APSS)

Pediatric Adverse Drug Events
21D Pediatric Adverse Drug Events

Executive Summary

The Problem The potential for adverse medication or drug-related errors is three times higher in the pediatric and neonatal populations than in the adult population (The Joint Commission, 2008). The Cost Studies estimate there exists an 11.1% adverse drug rate in the hospitalized pediatric population, with 2.5% leading to harm (The

Already a Community Member?

Please login to the PSMF Community to join the conversation and access the latest information on patient safety.


Not a Community Member?

Join the community with a bold vision of achieving ZERO preventable patient harm and deaths across the globe by 2030. I believe ZERO is the only acceptable number.

Join Our Community